These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32900514)

  • 21. Point-of-Care SARS-CoV-2 Variant Diagnostic in Development.
    Abbasi J
    JAMA; 2021 Sep; 326(10):901. PubMed ID: 34519815
    [No Abstract]   [Full Text] [Related]  

  • 22. An Overview of Deep Learning Techniques on Chest X-Ray and CT Scan Identification of COVID-19.
    Serena Low WC; Chuah JH; Tee CATH; Anis S; Shoaib MA; Faisal A; Khalil A; Lai KW
    Comput Math Methods Med; 2021; 2021():5528144. PubMed ID: 34194535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Less is more: an ecological and economic point of view on appropriate use of lab testing for COVID-19 patients.
    Signorini SG; Brugnoni D; Levaggi R; Garrafa E
    Bioanalysis; 2021 Dec; 13(24):1781-1783. PubMed ID: 34355575
    [No Abstract]   [Full Text] [Related]  

  • 24. Audio Interview: A Covid-19 Conversation with Anthony Fauci.
    Rubin EJ; Baden LR; Fauci AS; Morrissey S
    N Engl J Med; 2021 Jan; 384(4):e22. PubMed ID: 33503350
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances in electrical impedance tomography and bioimpedance including applications in COVID-19 diagnosis and treatment.
    Bayford R; Sadleir R; Frerichs I
    Physiol Meas; 2022 Mar; 43(2):. PubMed ID: 35254288
    [No Abstract]   [Full Text] [Related]  

  • 26. Positive pleural fluid RT-PCR for virus detection in SARS-CoV-2 pneumonia.
    Malik MI; Fox N; Chopra A; Hughes HY; Washburn R; Huggins JT
    QJM; 2020 Dec; 113(12):888-889. PubMed ID: 32936903
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical validation of a second generation anti-SARS-CoV-2 IgG and IgM automated chemiluminescent immunoassay.
    Pieri M; Nuccetelli M; Nicolai E; Sarubbi S; Grelli S; Bernardini S
    J Med Virol; 2021 Apr; 93(4):2523-2528. PubMed ID: 33463719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 and Diagnostic Testing for SARS-CoV-2 by RT-qPCR-Facts and Fallacies.
    Bustin S; Mueller R; Shipley G; Nolan T
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 'Great Imitator': A Case of COVID-19 Presenting with Encephalitis and Acute Coronary Syndrome.
    Darmawan G; Makmud ST
    Acta Med Indones; 2021 Jan; 53(1):82-85. PubMed ID: 33818410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strengths and weakness of diagnostic tests of SARS CoV-2 infection.
    Hernández-Pérez JM; Martín-González E; Pino-Yanes M
    Med Clin (Barc); 2020 Nov; 155(10):464-465. PubMed ID: 32546315
    [No Abstract]   [Full Text] [Related]  

  • 31. Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19.
    Krause E; Puyskens A; Bourquain D; Brinkmann A; Biere B; Schaade L; Michel J; Nitsche A
    Mol Cell Probes; 2021 Aug; 58():101742. PubMed ID: 33971264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 infection among hospitalised pregnant women and impact of different viral strains on COVID-19 severity in Italy: a national prospective population-based cohort study.
    Donati S; Corsi E; Maraschini A; Salvatore MA;
    BJOG; 2022 Jan; 129(2):221-231. PubMed ID: 34687585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2 in Israel and COVID-19 Covered by Israeli authors.
    Israeli E
    Isr Med Assoc J; 2021 Mar; 23(3):137-139. PubMed ID: 33734621
    [No Abstract]   [Full Text] [Related]  

  • 34. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 4 molecular assays for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Uprety P; Mathew J; Weinstein MP; Kirn TJ
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115196. PubMed ID: 33220615
    [No Abstract]   [Full Text] [Related]  

  • 36. Interpreting SARS-CoV-2 Test Results.
    Coffey KC; Diekema DJ; Morgan DJ
    JAMA; 2021 Oct; 326(15):1528-1529. PubMed ID: 34533581
    [No Abstract]   [Full Text] [Related]  

  • 37. Ozone therapy for the treatment of COVID-19 pneumonia: A scoping review.
    Izadi M; Cegolon L; Javanbakht M; Sarafzadeh A; Abolghasemi H; Alishiri G; Zhao S; Einollahi B; Kashaki M; Jonaidi-Jafari N; Asadi M; Jafari R; Fathi S; Nikoueinejad H; Ebrahimi M; Imanizadeh S; Ghazale AH
    Int Immunopharmacol; 2021 Mar; 92():107307. PubMed ID: 33476982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of hemogram and biochemical parameters in COVID-19 patients and their implication-A single-center prospective study in tertiary care hospital Islamabad, Pakistan.
    Ali S; Chaudry SS; Khan AQ; Shiekh AK; Tariq J; Tariq M; Nazli S; Khaliq T; Riaz SK
    Int J Lab Hematol; 2021 Jun; 43(3):e148-e151. PubMed ID: 33377579
    [No Abstract]   [Full Text] [Related]  

  • 39. Interest of the cellular population data analysis as an aid in the early diagnosis of SARS-CoV-2 infection.
    Vasse M; Ballester MC; Ayaka D; Sukhachev D; Delcominette F; Habarou F; Jolly E; Sukhacheva E; Pascreau T; Farfour É
    Int J Lab Hematol; 2021 Feb; 43(1):116-122. PubMed ID: 32812365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating sleep quality with coronavirus disease 2019 (COVID-19) testing.
    Viehmann-Wical K
    J Clin Sleep Med; 2021 Feb; 17(2):355. PubMed ID: 33141011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.